Correlation Between US Lithium and Mydecine Innovations

Can any of the company-specific risk be diversified away by investing in both US Lithium and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining US Lithium and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between US Lithium Corp and Mydecine Innovations Group, you can compare the effects of market volatilities on US Lithium and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in US Lithium with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of US Lithium and Mydecine Innovations.

Diversification Opportunities for US Lithium and Mydecine Innovations

0.12

Correlation Coefficient

US Lithium  Mydecine Innovations

Average diversification

The 3 months correlation between LITH and Mydecine is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding US Lithium Corp and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and US Lithium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US Lithium Corp are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of US Lithium i.e., US Lithium and Mydecine Innovations go up and down completely randomly.

Pair Corralation between US Lithium and Mydecine Innovations

Given the investment horizon of 90 days US Lithium Corp is expected to under-perform the Mydecine Innovations. But the stock apears to be less risky and, when comparing its historical volatility, US Lithium Corp is 3.62 times less risky than Mydecine Innovations. The stock trades about -0.13 of its potential returns per unit of risk. The Mydecine Innovations Group is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  0.80  in Mydecine Innovations Group on September 20, 2024 and sell it today you would lose (0.40) from holding Mydecine Innovations Group or give up 50.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

US Lithium Corp  vs.  Mydecine Innovations Group

US Lithium Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days US Lithium Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Mydecine Innovations

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with US Lithium and Mydecine Innovations

The main advantage of trading using opposite US Lithium and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if US Lithium position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.

The idea behind US Lithium Corp and Mydecine Innovations Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.